We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

Back to rankings

30 hedge funds and large institutions have $2.13M invested in Biostage, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

6% less funds holding

Funds holding: 32 → 30 (-2)

45% less capital invested

Capital invested by funds: $3.86M → $2.13M (-$1.73M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$55.3K
2
WIC
Woodmont Investment Counsel
Tennessee
+$27.8K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
+$11.3K
4
VKH
Virtu KCG Holdings
New York
+$10.2K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.11K

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$132K
2
BCM
Bridgeway Capital Management
Texas
-$41K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$40K
4
Deutsche Bank
Deutsche Bank
Germany
-$39.8K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$35.4K

BSTG Hedge Fund Activity: Q3 2015 in Review

30 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q3 2015, worth a combined $2.13M — down 45% from $3.86M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BSTG and 2 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $55.3K. The largest seller was Sio Capital Management, cutting an estimated $132K.

  • 30 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q3 2015, down from 32 in Q2 2015.
  • Funds reported $2.13M of Biostage, Inc. Common Stock stock for Q3 2015, down 45% quarter-over-quarter.
  • 2 funds opened new Biostage, Inc. Common Stock positions in Q3 2015 and 4 closed out, a net change of -2 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q3 2015 was Renaissance Technologies, an estimated $55.3K added.
  • The largest Biostage, Inc. Common Stock seller in Q3 2015 was Sio Capital Management, an estimated $132K sold.

Based on aggregated 13F filings for Q3 2015.